文献速递乳腺癌放疗

乳腺癌区域淋巴结照射靶区选择:网络Meta分析

Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysis.
PubMed 文献 · Radiat Oncol · 2019-06-11

该网络Meta分析纳入比较乳腺癌术后区域淋巴结照射不同靶区体积的随机研究和前瞻性队列研究,评估总生存、乳腺癌特异性生存、无病生存、无远处转移生存和局部区域控制。结果显示,在腋窝淋巴结清扫后,将照射野扩展至腋尖和锁骨上区可减少局部区域复发,但未改善总生存和乳腺癌特异性生存;只有包含内乳链才带来生存获益,源于远处转移的减少。

要点

  • 腋窝淋巴结清扫后,扩展至腋尖和锁骨上区可改善局部区域控制,但不改善总生存和乳腺癌特异性生存。
  • 包含内乳链的照射可改善总生存、乳腺癌特异性生存和无远处转移生存。
  • 内乳链照射的生存获益源于远处转移的减少。

核心结论

  • 腋窝淋巴结清扫后,将照射野扩展至腋尖和锁骨上区可减少局部区域复发,但未改善总生存和乳腺癌特异性生存。
  • 只有包含内乳链的区域淋巴结照射才带来生存获益,该获益源于远处转移的减少。

研究设计与样本

  • 网络Meta分析,纳入两项比较全面淋巴结照射与单纯乳腺照射的随机研究(n=5836)。
  • 纳入一项比较内乳链额外照射与单纯局部及锁骨上腋尖照射的随机研究(n=1407)和一项前瞻性队列研究(n=3377)。
  • 使用MetaXL V5.3软件,采用逆方差异质性模型进行网络Meta分析。

临床怎么用

  • 乳腺癌术后区域淋巴结照射决策时,应权衡靶区体积对局部区域控制与生存的不同影响。
  • 若目标是改善生存,需考虑包含内乳链的照射体积,因其与远处转移减少和生存改善相关。
  • 仅扩展至腋尖和锁骨上区虽可改善局部区域控制,但未显示总生存获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE/OBJECTIVE(S): Radiation treatment to the regional nodes results in an improvement in survival in breast cancer according to a meta-analysis of randomized trials. However, different volumes were targeted in these studies: breast or chestwall only (WBI/CWI), inclusion of the medial supraclavicular region and axillary apex (MS + WBI/CWI) or additional inclusion of the internal mammary chain (IM + MS + WBI/CWI). The benefit of treating the medial supraclavicular region and axillary apex compared to tangential breast or chestwall irradiation only remains unclear. MATERIALS/METHODS: A literature search was conducted identifying trials for adjuvant radiation volumes in nodal irradiation after breast surgery and axillary treatment. Events and effect sizes were extracted from the publications for the endpoints of overall survival (OS), breast cancer-specific survival (BCSS), disease-free survival (DFS), distant metastasis-free survival (DMFS) and loco-regional control (LRC). A network meta-analysis was performed using MetaXL V5.3 with the inverse variance heterogeneity model. RESULTS: We found two randomized studies (n = 5836) comparing comprehensive nodal irradiation to sole breast treatment as well as one randomized (n = 1407) and one prospective cohort study (n = 3377) analysing the additional treatment of the internal mammary chain against sole local and supraclavicular and axillary apex radiation. Compared to WBI/CWI alone the treatment of IM + MS + WBI/CWI (HR = 0.88; CI:0.78-0.99; p = 0.036) results in improved OS unlike MS + WBI/CWI (HR = 0.99; CI:0.86-1.14; p = 0,89). These results are confirmed in BCSS: IM + MS + WBI/CWI (HR = 0.82; CI:0.72-0.92; p = 0.002) and MS + WBI/CWI (HR = 0.96; CI:0.79-1.18; p = 0.69). PFS is significantly improved with the treatment of MS + WBI/CWI (OR = 0.83; CI:0.71-0.97; p = 0.019). Both nodal treatment volumes improve LRC (MS + WBI/CWI OR = 0.74; CI:0.62-0.87; p = 0.004 and IM + MS + WBI/CWI OR = 0.60; CI:0.43-0.86; p < 0,001). Yet only the internal mammary nodes provide a benefit in DMFS (MS + WBI/CWI HR = 0.97; CI:0.81-1.16; p = 0.74 and IM + MS + WBI/CWI HR = 0.84; CI:0.75-0.94; p = 0.002). CONCLUSION: Expanding the radiation field to the axillary apex and supraclavicular nodes after axillary node dissection reduced loco-regional recurrences without improvement in overall and cancer-specific survival. A prolongation in survival due to regional nodal irradiation is achieved when the internal mammary chain is included. This derives from a reduction in distant metastasis.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Haussmann J, Budach W, Tamaskovics B, et al. Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysis. Radiat Oncol. 2019. PMID: 31186015. doi:10.1186/s13014-019-1280-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。